{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:18:19Z","timestamp":1793413099754,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/iae.0b013e318297a07a","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T12:58:48Z","timestamp":1369832328000},"page":"2096-2102","source":"Crossref","is-referenced-by-count":179,"title":["MINERALOCORTICOID RECEPTOR ANTAGONISM IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"33","author":[{"given":"Elodie","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Offret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":". The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":". Central serous chorioretinopathy.","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology.","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Experiment Ophthalmol"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10792-009-9302-2","article-title":". Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.","volume":"30","author":"Gupta","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":". Diagnosis and interventions for central serous chorioretinopathy: review and update.","volume":"41","author":"Quin","year":"2013","journal-title":"Clin Experiment Ophthalmol"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.ophtha.2012.02.021","article-title":". Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.","volume":"119","author":"Jirarattanasopa","year":"2012","journal-title":"Ophthalmology"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IAE.0b013e31820f4b39","article-title":". Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":". Indocyanine green videoangiography of older patients with central serous chorioretinopathy.","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00006982-199919060-00005","article-title":"Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.","volume":"19","author":"Iida","year":"1999","journal-title":"Retina"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids.","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":". Systemic findings associated with central serous chorioretinopathy.","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":". Risk factors for central serous chorioretinopathy: a case-control study.","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity.","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":". The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells.","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":". Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":". Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/17425250902837973","article-title":"3rd, Schoenhard JA, Benge CD. The clinical pharmacology of eplerenone.","volume":"5","author":"Muldowney","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bjophthalmol-2011-300183","article-title":"Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy.","volume":"96","author":"Steinle","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":". Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy.","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy.","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":". Finasteride for chronic central serous chorioretinopathy.","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.","volume":"95","author":"Robertson","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":". Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/112067210901900415","article-title":". Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.","volume":"19","author":"Schaal","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":". Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e318297a07a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:46:24Z","timestamp":1620938784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201311000-00014"}},"subtitle":["A Pilot Study"],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318297a07a","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718163904.793486347","asserted-by":"object"}]},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}